| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hebbar Sudarshan | Chief Medical Officer | C/O CALCIMEDICA, INC., 505 COAST S. BLVD. #307, LA JOLLA | /s/ John Dunn, Esq., Attorney-in-Fact | 18 Aug 2025 | 0001968793 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CALC | Common Stock | Purchase | $4,095 | +1,584 | +3.4% | $2.58 | 47,584 | 14 Aug 2025 | Direct | F1 |
| transaction | CALC | Common Stock | Purchase | $12,267 | +4,392 | +9.2% | $2.79 | 51,976 | 15 Aug 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The weighted average purchase price for the transaction reported was $2.585, and the range of prices were between $2.57 and $2.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |
| F2 | The weighted average purchase price for the transaction reported was $2.7930, and the range of prices were between $2.70 and $2.85. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |